CorMedix Inc (NYSE MKT LLC:CRMD)

During the Trading Day
5.62 +0.46 / +8.91%
As of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.56 -0.06 / -1.07%
 
Volume: 5.0K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$115.9M

Company Description

CorMedix, Inc. is a development stage pharmaceutical and medical device company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, specifically in the dialysis and non-dialysis areas. The company's products are Neutrolin CRMD003, Thixotropic Gel CRMD004, Deferiprone CRMD001 and Urine Catalytic Test CRMD002. CorMedix was founded on July 28, 2006 and is headquartered in Bridgewater, NJ.

Contact Information

CorMedix, Inc.
745 Route 202-206
Bridgewater New Jersey 08807
P:(908) 517-9500
Investor Relations:
(908) 517-9489

Employees

Shareholders

Other institutional14.79%
Individual stakeholders11.23%
Mutual fund holders1.79%

Top Executives

Randy D. MilbyCEO, Director & Head-Media Relations
Harry O'GradyChief Financial Officer
Antony E. PfaffleVice Chairman, Secretary & CSO
William J. VanjonackVice President-Manufacturing & Quality Operations

To view my watchlist

Not a member yet?

Sign up now for a free account